kro-10q_20180331.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended March 31, 2018

Commission file number 1-31763

 

KRONOS WORLDWIDE, INC.

(Exact name of Registrant as specified in its charter)

 

 

DELAWARE

 

76-0294959

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

5430 LBJ Freeway, Suite 1700

Dallas, Texas 75240-2620

(Address of principal executive offices)

Registrant’s telephone number, including area code: (972) 233-1700

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes      No  

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer          

Accelerated filer  

Non-accelerated filer (Do not check if a smaller reporting company)        

  Smaller reporting company    

Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the  extended  transition period for complying with any new or revised financial accounting standards provided  pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes      No  

Number of shares of the Registrant’s common stock outstanding on April 30, 2018:  115,902,098.

 

 

 


 

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

INDEX

 

 

  

 

  

Page
number

 

Part I.

  

FINANCIAL INFORMATION

  

 

 

Item 1.

  

Financial Statements

  

 

 

  

 

Condensed Consolidated Balance Sheets -
   December 31, 2017; March 31, 2018 (unaudited)

  

3

 

  

 

Condensed Consolidated Statements of Income (unaudited) -
   Three months ended March 31, 2017 and 2018

  

5

 

  

 

Condensed Consolidated Statements of Comprehensive Income (unaudited) -
   Three months ended March 31, 2017 and 2018

  

6

 

  

 

Condensed Consolidated Statement of Stockholders’ Equity (unaudited) -
   Three months ended March 31, 2018

  

7

 

  

 

Condensed Consolidated Statements of Cash Flows (unaudited) -
   Three months ended March 31, 2017 and 2018

  

8

 

  

 

Notes to Condensed Consolidated Financial Statements (unaudited)

  

9

Item 2.

  

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

20

Item 3.

  

 

Quantitative and Qualitative Disclosure About Market Risk

  

29

Item 4.

  

 

Controls and Procedures

  

29

 

Part II.

  

OTHER INFORMATION

  

 

 

Item 1.

  

Legal Proceedings

  

31

Item 1A.

  

 

Risk Factors

  

31

Item 6.

  

 

Exhibits

  

31

 

Items 2, 3, 4 and 5 of Part II are omitted because there is no information to report.

  

 

 

 

 

 

- 2 -


 

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions)

 

 

 

December 31,

 

 

March 31,

 

 

2017

 

 

2018

 

 

 

 

 

 

(unaudited)

 

ASSETS

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

Cash and cash equivalents

$

322.0

 

 

$

364.6

 

Restricted cash

 

1.7

 

 

 

1.3

 

Accounts and other receivables

 

346.5

 

 

 

390.2

 

Inventories, net

 

382.3

 

 

 

430.2

 

Prepaid expenses and other

 

10.0

 

 

 

9.2

 

 

 

 

 

 

 

 

 

Total current assets

 

1,062.5

 

 

 

1,195.5

 

 

 

 

 

 

 

 

 

Other assets:

 

 

 

 

 

 

 

Investment in TiO2 manufacturing joint venture

 

86.5

 

 

 

79.6

 

Marketable securities

 

10.7

 

 

 

10.5

 

Note receivable from Valhi

 

13.6

 

 

 

-

 

Deferred income taxes

 

139.2

 

 

 

132.3

 

Other

 

5.5

 

 

 

6.6

 

 

 

 

 

 

 

 

 

Total other assets

 

255.5

 

 

 

229.0

 

 

 

 

 

 

 

 

 

Property and equipment:

 

 

 

 

 

 

 

Land

 

42.0

 

 

 

43.2

 

Buildings

 

221.6

 

 

 

225.3

 

Equipment

 

1,103.2

 

 

 

1,158.1

 

Mining properties

 

115.7

 

 

 

123.7

 

Construction in progress

 

52.6

 

 

 

27.0

 

 

 

1,535.1

 

 

 

1,577.3

 

Less accumulated depreciation and amortization

 

1,028.7

 

 

 

1,063.2

 

 

 

 

 

 

 

 

 

Net property and equipment

 

506.4

 

 

 

514.1

 

 

 

 

 

 

 

 

 

Total assets

$

1,824.4

 

 

$

1,938.6

 

 

- 3 -


 

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

(In millions)

 

 

 

December 31,

 

 

March 31,

 

 

2017

 

 

2018

 

 

 

 

 

 

(unaudited)

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

Current maturities of long-term debt

$

.7

 

 

$

.7

 

Accounts payable and accrued liabilities

 

205.8

 

 

 

227.9

 

Income taxes

 

25.0

 

 

 

32.5

 

 

 

 

 

 

 

 

 

Total current liabilities

 

231.5

 

 

 

261.1

 

 

 

 

 

 

 

 

 

Noncurrent liabilities:

 

 

 

 

 

 

 

Long-term debt

 

473.8

 

 

 

487.4

 

Accrued pension costs

 

254.2

 

 

 

260.1

 

Accrued postretirement benefits costs

 

7.7

 

 

 

7.5

 

Payable to affiliate

 

70.1

 

 

 

70.1

 

Deferred income taxes

 

11.3

 

 

 

11.5

 

Other

 

21.5

 

 

 

22.6

 

 

 

 

 

 

 

 

 

Total noncurrent liabilities

 

838.6

 

 

 

859.2

 

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

Common stock

 

1.2

 

 

 

1.2

 

Additional paid-in capital

 

1,399.0

 

 

 

1,399.0

 

Retained deficit

 

(267.2

)

 

 

(211.4

)

Accumulated other comprehensive loss

 

(378.7

)

 

 

(370.5

)

 

 

 

 

 

 

 

 

Total stockholders' equity

 

754.3

 

 

 

818.3

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

$

1,824.4

 

 

$

1,938.6

 

Commitments and contingencies (Notes 11 and 13)

See accompanying notes to Condensed Consolidated Financial Statements.  

 

- 4 -


 

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In millions, except per share data)

 

 

 

Three months ended

 

 

March 31,

 

 

2017

 

 

2018

 

 

(unaudited)

 

Net sales

$

369.8

 

 

$

430.4

 

Cost of sales

 

263.8

 

 

 

255.6

 

 

 

 

 

 

 

 

 

Gross margin

 

106.0

 

 

 

174.8

 

 

 

 

 

 

 

 

 

Selling, general and administrative expense

 

45.3

 

 

 

58.4

 

Other operating income (expense):

 

 

 

 

 

 

 

Currency transaction losses, net

 

(.2

)

 

 

(5.0

)

Other operating expense, net

 

(4.1

)

 

 

(3.9

)

 

 

 

 

 

 

 

 

Income from operations

 

56.4

 

 

 

107.5

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

Interest and dividend income

 

.2

 

 

 

1.0

 

Securities transactions, net

 

-

 

 

 

(.2

)

Other components of net periodic pension and OPEB cost

 

(4.1

)

 

 

(3.8

)

Interest expense

 

(4.7

)

 

 

(4.8

)

 

 

 

 

 

 

 

 

Income before income taxes

 

47.8

 

 

 

99.7

 

 

 

 

 

 

 

 

 

Income tax expense

 

11.0

 

 

 

29.0

 

 

 

 

 

 

 

 

 

Net income

$

36.8

 

 

$

70.7

 

 

 

 

 

 

 

 

 

Net income per basic and diluted share

$

.32

 

 

$

.61

 

 

 

 

 

 

 

 

 

Cash dividends per share

$

.15

 

 

$

.17

 

 

 

 

 

 

 

 

 

Weighted average shares used in the calculation

  of net income per share

 

115.9

 

 

 

115.9

 

 

See accompanying notes to Condensed Consolidated Financial Statements.  

 

- 5 -


 

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In millions)

 

 

 

Three months ended

 

 

March 31,

 

 

2017

 

 

2018

 

 

(unaudited)

 

Net income

$

36.8

 

 

$

70.7

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss), net of tax:

 

 

 

 

 

 

 

Currency translation

 

9.0

 

 

 

10.7

 

Marketable securities

 

(.2

)

 

 

-

 

Defined benefit pension plans

 

3.1

 

 

 

2.4

 

Other postretirement benefit plans

 

(.1

)

 

 

(.1

)

Interest rate swap

 

.6

 

 

 

-

 

 

 

 

 

 

 

 

 

Total other comprehensive income, net

 

12.4

 

 

 

13.0

 

 

 

 

 

 

 

 

 

Comprehensive income

$

49.2

 

 

$

83.7

 

 

See accompanying notes to Condensed Consolidated Financial Statements.

 

- 6 -


 

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

Three months ended March 31, 2018

(In millions)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Retained

 

 

other

 

 

 

 

 

 

Common

 

 

paid-in

 

 

earnings

 

 

comprehensive

 

 

 

 

 

 

stock

 

 

capital

 

 

(deficit)

 

 

loss

 

 

Total

 

 

(unaudited)

 

Balance at December 31, 2017

$

1.2

 

 

$

1,399.0

 

 

$

(267.2

)

 

$

(378.7

)

 

$

754.3

 

Change in accounting principle - ASU 2016-01

 

-

 

 

 

-

 

 

 

4.8

 

 

 

(4.8

)

 

 

-

 

Balance at January 1, 2018, as adjusted

 

1.2

 

 

 

1,399.0

 

 

 

(262.4

)

 

 

(383.5

)

 

 

754.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

-

 

 

 

-

 

 

 

70.7

 

 

 

-

 

 

 

70.7

 

Other comprehensive income, net of tax

 

-

 

 

 

-

 

 

 

-

 

 

 

13.0

 

 

 

13.0

 

Dividends paid

 

-

 

 

 

-

 

 

 

(19.7

)

 

 

-

 

 

 

(19.7

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at March 31, 2018

$

1.2

 

 

$

1,399.0

 

 

$

(211.4

)

 

$

(370.5

)

 

$

818.3

 

 

See accompanying notes to Condensed Consolidated Financial Statements.

 

- 7 -


 

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

 

Three months ended

 

 

March 31,

 

 

2017

 

 

2018

 

 

(unaudited)

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net income

$

36.8

 

 

$

70.7

 

Depreciation and amortization

 

10.1

 

 

 

12.3

 

Deferred income taxes

 

3.0

 

 

 

9.4

 

Benefit plan expense greater than cash funding

 

3.7

 

 

 

.9

 

Distributions from (contributions to) TiO2 manufacturing joint venture, net

 

(3.1

)

 

 

5.5

 

Other, net

 

.5

 

 

 

1.1

 

Change in assets and liabilities:

 

 

 

 

 

 

 

Accounts and other receivables

 

(26.8

)

 

 

(38.7

)

Inventories

 

(12.1

)

 

 

(40.9

)

Prepaid expenses

 

1.4

 

 

 

1.0

 

Accounts payable and accrued liabilities

 

21.5

 

 

 

28.6

 

Income taxes

 

4.7

 

 

 

6.7

 

Accounts with affiliates

 

(.8

)

 

 

.4

 

Other, net

 

2.7

 

 

 

1.2

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

41.6

 

 

 

58.2

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Capital expenditures

 

(11.9

)

 

 

(15.2

)

Loan to Valhi:

 

 

 

 

 

 

 

Loans

 

-

 

 

 

(.8

)

Collections

 

-

 

 

 

14.4

 

 

 

 

 

 

 

 

 

Net cash used in investing activities

 

(11.9

)

 

 

(1.6

)

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Indebtedness:

 

 

 

 

 

 

 

Borrowings

 

42.2

 

 

 

-

 

Principal payments

 

(17.1

)

 

 

(.1

)

Deferred financing fees

 

(.1

)

 

 

-

 

Dividends paid

 

(17.4

)

 

 

(19.7

)

 

 

 

 

 

 

 

 

Net cash provided by (used in) financing activities

 

7.6

 

 

 

(19.8

)

 

 

 

 

 

 

 

 

Cash, cash equivalents and restricted cash - net change from:

 

 

 

 

 

 

 

Operating, investing and financing activities

$

37.3

 

 

$

36.8

 

Currency translation

 

1.3

 

 

 

5.4

 

Balance at beginning of period

 

52.3

 

 

 

323.7

 

 

 

 

 

 

 

 

 

Balance at end of period

$

90.9

 

 

$

365.9

 

 

 

 

 

 

 

 

 

Supplemental disclosures:

 

 

 

 

 

 

 

Cash paid for:

 

 

 

 

 

 

 

Interest, net of amount capitalized

$

4.2

 

 

$

9.1

 

Income taxes

 

2.1

 

 

 

14.0

 

Accrual for capital expenditures

 

4.2

 

 

 

2.5

 

See accompanying notes to Condensed Consolidated Financial Statements.


 

- 8 -


 

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2018

(unaudited)

 

Note 1 - Organization and basis of presentation:

Organization - At March 31, 2018, Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL) held approximately 30% of our common stock, Valhi owned approximately 83% of NL’s outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 93% of Valhi’s outstanding common stock.  All of Contran’s outstanding voting stock is held by a family trust established for the benefit of Lisa K. Simmons and Serena Simmons Connelly and their children, for which Ms. Simmons and Ms. Connelly are co-trustees, or is held directly by Ms. Simmons and Ms. Connelly or entities related to them.  Consequently, Ms. Simmons and Ms. Connelly may be deemed to control Contran, Valhi, NL and us.

Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2017 that we filed with the Securities and Exchange Commission (“SEC”) on March 12, 2018 (“2017 Annual Report”).  In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments), in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented.  We have condensed the Consolidated Balance Sheet at December 31, 2017 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2017) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).  Our results of operations for the interim period ended March 31, 2018 may not be indicative of our operating results for the full year.  The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2017 Consolidated Financial Statements contained in our 2017 Annual Report.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its subsidiaries (NYSE: KRO) taken as a whole.

Note 2 - Accounts and other receivables:

 

 

December 31,

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Trade receivables

$

301.4

 

 

$

347.3

 

Recoverable VAT and other receivables

 

19.0

 

 

 

17.1

 

Receivable from affiliates:

 

 

 

 

 

 

 

Income taxes, net - Valhi

 

15.3

 

 

 

14.3

 

Louisiana Pigment Company, L.P. ("LPC")

 

8.9

 

 

 

9.4

 

Other

 

3.2

 

 

 

3.4

 

Refundable income taxes

 

.1

 

 

 

.2

 

Allowance for doubtful accounts

 

(1.4

)

 

 

(1.5

)

Total

$

346.5

 

 

$

390.2

 

 

Note 3 - Inventories, net:

 

 

December 31,

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Raw materials

$

106.9

 

 

$

105.4

 

Work in process

 

20.8

 

 

 

37.1

 

Finished products

 

191.5

 

 

 

219.8

 

Supplies

 

63.1

 

 

 

67.9

 

Total

$

382.3

 

 

$

430.2

 

 

- 9 -


 

 

Note 4 - Marketable securities:

Our marketable securities consist of investments in the publicly-traded shares of related parties: Valhi, NL and CompX International Inc.  NL owns the majority of CompX’s outstanding common stock.  All of our marketable securities are accounted for as available-for-sale securities, which are carried at fair value using quoted market prices in active markets for each marketable security.   Prior to 2018, any unrealized gains or losses on the securities were recognized through other comprehensive income, net of deferred income taxes.  Beginning on January 1, 2018 with the adoption of Accounting Standards Update (“ASU”) 2016-01, all of our marketable equity securities will continue to be carried at fair value as noted above, but any unrealized gains or losses on the securities are now recognized as a component of other income included in the Securities transactions, net on our Condensed Consolidated Statements of Income.  The fair value of our equity securities represent a Level 1 input within the fair value hierarchy.  See Note 14.

 

 

 

Fair value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

measurement

 

Market

 

 

Cost

 

 

 

 

 

Marketable security

 

level

 

value

 

 

basis

 

 

Unrealized gain

 

 

 

 

 

(In millions)

 

December 31, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Valhi common stock

 

1

 

$

10.6

 

 

$

3.2

 

 

$

7.4

 

NL and CompX common stocks

 

1

 

 

.1

 

 

 

.1

 

 

 

-

 

Total

 

 

 

$

10.7

 

 

$

3.3

 

 

$

7.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Valhi common stock

 

1

 

$

10.4

 

 

$

3.2

 

 

$

7.2

 

NL and CompX common stocks

 

1

 

 

.1

 

 

 

.1

 

 

 

-

 

Total

 

 

 

$

10.5

 

 

$

3.3

 

 

$

7.2

 

At December 31, 2017 and March 31, 2018, we held approximately 1.7 million shares of Valhi’s common stock.  We also held a nominal number of shares of CompX and NL common stocks.  At December 31, 2017 and March 31, 2018, the quoted per share market price of Valhi’s common stock was $6.17 and $6.06, respectively.  During the first three months of 2018 we recognized a securities transactions loss of $.2 million related to the aggregate net change in market value of our marketable equity securities during such period.

The Valhi, CompX and NL common stocks we own are subject to the restrictions on resale pursuant to certain provisions of SEC Rule 144.  In addition, as a majority-owned subsidiary of Valhi we cannot vote our shares of Valhi common stock under Delaware General Corporation law, but we do receive dividends from Valhi on these shares, when declared and paid.

Note 5 - Other noncurrent assets:

 

 

December 31,

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Pension asset

$

1.6

 

 

$

3.4

 

Deferred financing costs, net

 

1.1

 

 

 

1.1

 

Other

 

2.8

 

 

 

2.1

 

Total

$

5.5

 

 

$

6.6

 

Note 6 - Long-term debt:

 

December 31,

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Kronos International, Inc. 3.75% Senior Secured Notes

$

471.1

 

 

$

484.9

 

Other

 

3.4

 

 

 

3.2

 

Total debt

 

474.5

 

 

 

488.1

 

Less current maturities

 

.7

 

 

 

.7

 

Total long-term debt

$

473.8

 

 

$

487.4

 

Senior Secured Notes - At March 31, 2018, the carrying value of our 3.75% Senior Secured Notes due September 15, 2025 (€400 million aggregate principal amount outstanding) is stated net of unamortized debt issuance costs of $7.5 million.  

 

- 10 -


 

Revolving credit facilities – During the first three months of 2018, we had no borrowings or repayments under our North American revolving credit facility and our European revolving credit facility.  At March 31, 2018, approximately $115.2 million was available for additional borrowing under the North American revolving credit facility.  Our European revolving credit facility requires the maintenance of certain financial ratios, and one of such requirements is based on the ratio of net debt to last twelve months earnings before income tax, interest, depreciation and amortization expense (“EBITDA”) of the borrowers.  Based upon the borrowers’ last twelve months EBITDA as of March 31, 2018 and the net debt to EBITDA financial test, the full €90 million amount of the credit facility ($110.8 million) is available for borrowing at March 31, 2018.  

Other - We are in compliance with all of our debt covenants at March 31, 2018.

Note 7 - Accounts payable and accrued liabilities:

 

December 31,

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Accounts payable

$

107.9

 

 

$

117.4

 

Employee benefits

 

27.0

 

 

 

31.1

 

Accrued sales discounts and rebates

 

11.7

 

 

 

27.5

 

Payable to affiliate - LPC

 

16.2

 

 

 

13.7

 

Other

 

43.0

 

 

 

38.2

 

Total

$

205.8

 

 

$

227.9

 

 

Note 8 - Other noncurrent liabilities:

 

December 31,

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Employee benefits

$

8.5

 

 

$

8.9

 

Other

 

13.0

 

 

 

13.7

 

Total

$

21.5

 

 

$

22.6

 

Note 9 - Revenue recognition:

Our sales involve single performance obligations to ship our products pursuant to customer purchase orders.  In some cases, the purchase order is supported by an underlying master sales agreement, but our purchase order acceptance generally evidences the contract with our customer by specifying the key terms of product and quantity ordered, price and delivery and payment terms.  Effective January 1, 2018 with the adoption of ASU 2014-09, Revenue from Contracts with Customers (Topic 606), see Note 15, we record revenue when we satisfy our performance obligation to our customers by transferring control of our products to them, which generally occurs at point of shipment or upon delivery.  Such transfer of control is also evidenced by transfer of legal title and other risks and rewards of ownership (giving the customer the ability to direct the use of, and obtain substantially all of the benefits of, the product), and our customers becoming obligated to pay us and such payment is probable of occurring.  In certain arrangements we provide shipping and handling activities after the transfer of control to our customer (e.g. when control transfers prior to delivery) that are considered fulfillment activities, and accordingly, such costs are accrued when the related revenue is recognized. Sales arrangements with consignment customers occur when our product is shipped to a consignment customer location but we maintain control until the product is used in the customer’s manufacturing process.  In these instances, we recognize sales when the consignment customer uses our product, as control of our product has not passed to the customer until that time and all other revenue recognition criteria have been satisfied.  

Revenue is recorded in an amount that reflects the net consideration we expect to receive in exchange for our products.  Prices for our products are based on terms specified in published list prices and purchase orders, which generally do not include financing components, noncash consideration or consideration paid to our customers.  As our standard payment terms are less than one year, we have elected the practical expedient under ASC 606 and have not assessed whether a contract has a significant financing component.  We state sales net of price, early payment, and distributor discounts and volume rebates (collectively, variable consideration).  Variable consideration, to the extent present, is recognized as the amount to which we are most-likely to be entitled, using all information (historical, current and forecasted) that is reasonably available to us, and only to the extent that a significant reversal in the amount of the cumulative revenue recognized is not probable of occurring in a future period.  Differences, if any, between estimates of the amount of variable consideration to which we will be entitled and the actual amount of such variable consideration have not been material in the past.  Amounts received or receivable from our customers with respect to variable consideration we expect to refund to our customers is recognized as a current liability and classified as accrued sales discounts and rebates (see Note 7).  We report any tax assessed by a governmental authority that we collect from our customers that is both imposed on and concurrent

 

- 11 -


 

with our revenue-producing activities (such as sales, use, value added and excise taxes) on a net basis (meaning we do not recognize these taxes either in our revenues or in our costs and expenses).

Frequently, we receive orders for products to be delivered over dates that may extend across reporting periods. We invoice for each delivery upon shipment and recognize revenue for each distinct shipment when all sales recognition criteria for that shipment have been satisfied. As scheduled delivery dates for these orders are within a one year period, under the optional exemption provided by ASC 606, we do not disclose sales allocated to future shipments of partially completed contracts.

The following table disaggregates our net sales by place of manufacture (point of origin) and to the location of the customer (point of destination), which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors (as required by ASC 606).

 

Three months ended

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Net sales - point of origin:

 

 

 

 

 

 

 

Germany

$

183.6

 

 

$

234.5

 

United States

 

205.7

 

 

 

196.8

 

Canada

 

77.9

 

 

 

71.6

 

Belgium

 

58.1

 

 

 

69.7

 

Norway

 

47.3

 

 

 

53.1

 

Eliminations

 

(202.8

)

 

 

(195.3

)

Total

$

369.8

 

 

$

430.4

 

 

 

 

 

 

 

 

 

Net sales - point of destination:

 

 

 

 

 

 

 

Europe

$

179.7

 

 

$

233.9

 

North America

 

124.0

 

 

 

127.0

 

Other

 

66.1

 

 

 

69.5

 

Total

$

369.8

 

 

$

430.4

 

Note 10 - Employee benefit plans:

The components of net periodic defined benefit pension cost are presented in the table below.

 

Three months ended

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Service cost

$

2.7

 

 

$

3.0

 

Interest cost

 

3.3

 

 

 

3.6

 

Expected return on plan assets

 

(2.5

)

 

 

(3.4

)

Amortization of prior service cost

 

.1

 

 

 

.1

 

Recognized actuarial losses

 

3.2

 

 

 

3.5

 

Total

$

6.8

 

 

$

6.8

 

The components of net periodic postretirement benefits other than pension (“OPEB”) cost are presented in the table below.  

 

Three months ended

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Interest cost

$

.1

 

 

$

.1

 

Amortization of prior service credit

 

(.1

)

 

 

(.2

)

Recognized actuarial losses

 

-

 

 

 

.1

 

Total

$

-

 

 

$

-

 

 

- 12 -


 

Upon the adoption of ASU 2017-07, Compensation - Retirement Benefits (Topic 715) Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, our net periodic defined benefit pension cost and other postretirement benefit cost, other than the service cost component, is presented as a separate line item (“Other components of net periodic pension and OPEB cost”) in our Condensed Consolidated Statements of Income for all periods presented.  See Note 15.

We expect our 2018 contributions for our pension and other postretirement plans to be approximately $17 million.

Note 11 - Income taxes:

 

 

Three months ended

 

 

March 31,

 

 

2017

 

 

2018

 

 

(In millions)

 

Expected tax expense, at U.S. federal statutory

    income tax rate of 35% in 2017 and 21% in 2018

$

16.7

 

 

$

20.9

 

Non-U.S. tax rates

 

(2.4

)

 

 

7.1

 

Incremental net tax expense (benefit) on earnings and losses

    of U.S. and non-U.S. companies

 

1.2

 

 

 

.4

 

Valuation allowance

 

(5.0

)

 

 

-

 

Adjustment to reserve for uncertain tax positions, net

 

-

 

 

 

1.4

 

Canada-Germany APA

 

-

 

 

 

(1.4

)

Nondeductible expenses

 

-

 

 

 

.3

 

U.S. state income tax and other, net

 

.5

 

 

 

.3

 

Income tax expense

$

11.0

 

 

$

29.0

 

 

 

 

 

 

 

 

 

Comprehensive provision for income taxes allocable to:

 

 

 

 

 

 

 

Net income

$

11.0

 

 

$

29.0

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

Pension plans

 

.2

 

 

 

1.1

 

Marketable securities

 

(.1

)

 

 

-

 

Interest rate swap

 

.3

 

 

 

-

 

Total

$

11.4

 

 

$

30.1

 

 

The amount shown in the above table of our income tax rate reconciliation for non-U.S. tax rates represents the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by the difference between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal statutory tax rate of 35% in 2017 and 21% in 2018.  The amount shown on such table for incremental net tax expense (benefit) on earnings and losses of U.S. and non-U.S. companies includes, as applicable, (i) deferred income taxes (or deferred income tax benefits) associated with the current-year change in the aggregate amount of undistributed earnings of our Canadian subsidiary and, beginning in 2018, the post-1986 undistributed earnings of our European subsidiaries (such post-1986 undistributed earnings were subject to a permanent reinvestment plan until December 31, 2017) and (ii) current U.S. income taxes (or current income tax benefit), including U.S. personal holding company tax, as applicable, attributable to current-year income (losses) of one of our non-U.S. subsidiaries, which subsidiary is treated as a dual resident for U.S. income tax purposes, to the extent the current-year income (losses) of such subsidiary is subject to U.S. income tax under the U.S. dual-resident provisions of the Internal Revenue Code.

We have substantial net operating loss (“NOL”) carryforwards in Germany (the equivalent of $652 million for German corporate purposes and $.5 million for German trade tax purposes at December 31, 2017) and in Belgium (the equivalent of $50 million for Belgian corporate tax purposes at December 31, 2017), all of which have an indefinite carryforward period.  As a result, we have net deferred income tax assets with respect to these two jurisdictions, primarily related to these NOL carr